Financials
- Market Capitalization 2.02 B
- Employee 136
- Founded 2013
- CEO N/A
- Website www.amylyx.com
- Headquarter Delaware, United States
- FIGI BBG00DP10YT5
- Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-9.39
Rapporto prezzo/fatturato
—
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 1970 | AUPH Aurinia Pharmaceuticals Inc - Common Shares | 15.98 USD | -0.31% | -0.62% | -0.62% | +33.95% | 2.06 B USD | ||
| 1971 | NUVB Nuvation Bio Inc. Class A Common Stock | 5.90 USD | +2.43% | +6.50% | +15.23% | +174.42% | 2.05 B USD | ||
| 1983 | NBTX Nanobiotix S.A. - ADSs | 41.64 USD | +6.36% | +10.25% | +17.63% | +690.13% | 2.02 B USD | ||
| 1984 | HRMY Harmony Biosciences Holdings, Inc. - Common Stock | 34.81 USD | -2.05% | -8.30% | +1.25% | +12.65% | 2.02 B USD |